2019 annual financial data

Indivior Pharmaceuticals 2019 Operating margin

Indivior Pharmaceuticals 2019 operating margin with verified reported values.

Direct answer

Operating margin was 22.68%.

Operating income was 178,000,000 USD and net income was 134,000,000 USD.
Operating cash flow was 151,000,000 USD.

Get free Indivior Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
785,000,000 USD
Operating income
178,000,000 USD
Net income
134,000,000 USD
Operating cash flow
151,000,000 USD